Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, UB9 6NS, UK
Elantan LA 25 mg prolonged release capsules.
| Pharmaceutical Form |
|---|
|
Prolonged release capsules. Hard capsule with brown cap and white body, containing white to off-white pellets. |
Each prolonged release capsule contains 25 mg isosorbide mononitrate.
Excipients: Each prolonged release hard capsule contains 6.71 mg lactose monohydrate and approximately 8-12 mg sucrose.
For a full excipient list, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Isosorbide mononitrate |
Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Capule shell: Gelatin |
Cartons of blister strips of PVC and aluminium or of PP and aluminium.
Aluminium foil thickness 20 μm or 16 μm.
Pack size: 28 capsules.
Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, UB9 6NS, UK
PL 20011/0046
28 February 2008
| Drug | Countries | |
|---|---|---|
| ELANTAN | Estonia, Hong Kong, Ireland, Mexico, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
